Clinical Trial Update: Efficacy of Peginterferon Alpha 2a Therapy in Chronic Hepatitis B Patients Being Treated With Nucleoside(Acid) Analogues [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing the efficacy of peginterferon alfa-2a in chronic hepatitis B patients who are receiving nucleos(t)ide analogues.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Peginterferon alfa-2a (peginterferon alfa-2a)

Snippet

Sponsor: Beijing Ditan Hospital | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN